← Back to Search

Other

MHNA-003 for Tinnitus

N/A
Waitlist Available
Research Sponsored by Mahana Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 days
Treatment Varies
Follow Up 3 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing Mahana™ Tinnitus, a treatment for people who hear ringing in their ears. It involves about 250 adults who will use the treatment for several weeks. The goal is to see if it helps reduce their tinnitus symptoms.

Timeline

Screening ~ 3 days
Treatment ~ Varies
Follow Up ~3 days
This trial's timeline: 3 days for screening, Varies for treatment, and 3 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in TFI Score from Baseline to Week 6

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MHNA-003Experimental Treatment1 Intervention
6-week digital therapy program designed to reduce the severity of tinnitus symptoms

Find a Location

Logistics

Other reimbursement is provided

Other forms of reimbursement are provided for this trial.

Who is running the clinical trial?

Mahana TherapeuticsLead Sponsor
1 Previous Clinical Trials
194 Total Patients Enrolled
~34 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top